Malignant bowel obstruction: A review of current treatment strategies

American Journal of Hospice and Palliative Medicine

Volumn 28, Issue 8, 2011, Pages 576-582

  Dolan, Elisabeth A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

bowel obstruction; cancer

Indexed keywords

CORTICOSTEROID;

ANALGESIA; COLON; DECOMPRESSION SURGERY; HUMAN; INTESTINE OBSTRUCTION; METHODOLOGY; NAUSEA; NEOPLASM; PALLIATIVE THERAPY; PARENTERAL NUTRITION; QUALITY ADJUSTED LIFE YEAR; REVIEW; STENT; SURVIVAL;

ADRENAL CORTEX HORMONES; COLON; DECOMPRESSION, SURGICAL; HUMANS; INTESTINAL OBSTRUCTION; NAUSEA; NEOPLASMS; PAIN MANAGEMENT; PALLIATIVE CARE; PARENTERAL NUTRITION; QUALITY-ADJUSTED LIFE YEARS; STENTS; SURVIVAL ANALYSIS;

EID: 82955228917     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909111406706     Document Type: Review

References (55)

1. Ripamonti C,DeConno F,Ventafridda V,Rossi B,Baines MJ.Management of bowel obstruction in advance and terminal cancer patients.Ann Oncol. 1993;4 (1): 15-21.
2. Dvoretsky PM,Richards KA,Angel C, et al.Distrubution of disease at autopsy in 100 women with ovarian cancer.Hum Pathol. 1988;19 (1): 57-63.
3. Filippone A,Cianci R,Storto ML.Bowel obstruction: comparison between multidetector CT axial and coronal planes.Abdom Imaging. 2007;32 (3): 310-316.
4. Ripamonti CI,Easson AM,Gerdes H.Management of malignant bowel obstruction.Eur J Cancer. 2008;44 (8): 1105-1115.
5. Kim JH,Song H,Shin J, et al.Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients.Gastrointest Endosc. 2007;66 (2): 256-264.
6. Hosono S,Ohtani H,Arimoto Y,Kanamiya Y.Endoscopic stenting versus surgical gastoenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis.J Gastroenterol. 2007;42 (4): 283-290.
7. Graber I,Dumas R,Filoche B, et al.The efficacy and safety of duodenal stenting: a prospective multicenter study.Endoscopy. 2007;39 (9): 784-787.
8. Watt AM,Faragher IG,Griffin TT,Rieger NA,Maddern GJ.Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review.Ann Surg. 2007;246 (1): 24-30.
9. Tilney HS,Lovegrove RE,Purkayastha S, et al.Comparison of colonic stenting and open surgery for malignant large bowel obstruction.Surg Endosc. 2007;21 (2): 225-233.
10. Small AJ,Coelho-Prabhu N,Baron T.Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors.Gastrointest Endosc. 2010;71 (3): 560-572.
11. Jung MK,Park SY,Jeon SW, et al.Factors associated with the long-term outcome of a self-expandable colon stent used for palliation of malignant colorectal obstruction.Surg Endosc. 2010;24 (3): 525-530.
12. Dronamraju SS,Ramamurthy S,Kelly SB,Hayat M.Role of self-expanding metallic stents in the management of malignant obstruction of the proximal colon.Dis Colon. 2009;52 (9): 1657-1661.
13. Repici AR,Adler DG,Gibbs CM, et al.Stenting of the proximal colon in patients with malignant large bowel obstruction: techniques and outcomes.Gastrointest Endosc. 2007;66 (5): 940-944.
14. Stenhouse GJA,Page A,Rowan A,Giles L,Macdonald A.Self expanding wall stents in malignant colorectal cancer: is complete obstruction a contrindication to stent placement.Colorectal Dis. 2009;11 (8): 854-858.
15. Keswani RN,Azar RR,Edmundowicz SA, et al.Stenting for malignant colonic obstruction: a comparison of efficacy and complications in colonic versus extracolonic malignancy.Gastrointest Endosc. 2009;69 (3 pt 2): 675-680.
16. Caceres A,Zhou Q,Iasonos A, et al.Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.Gynecol Oncol. 2008;108 (3): 482-485.
17. Bielawska B,Hookey LC,Jalink D.Large-diameter self-expanding metal stents appear to be safe and effective for malignant colonic obstruction with and without concurrent use of chemotherapy.Surg Endosc. 2010;24 (11): 2814-2821.
18. Baron T.Colonic stenting: a palliative measure only or a bridge to surgery.Endoscopy. 2010;42 (2): 163-168.
19. Siddiqui A,Khandelwal N,Anthony T,Huerta S.Colinic stent versus surgery for the management of acute malignant colonic obstruction: a decision analysis.Aliment Pharmacol Ther. 2007;26 (10): 1379-1386.
20. Aragher IG,Chaitowitz IM,Stupart DA.Long-term results of palliative stenting or surgery for incurable obstructing colon cancer.Colorectal Dis. 2008;10 (7): 668-672.
21. Dastur JK,Forshaw MJ,Modarai B, et al.Comparison of short- and long-term outcomes following either insertion of self-expanding metallic stents or emergency surgery in malignant large bowel obstruction.Techn Coloproctol. 2008;12 (1): 51-55.
22. Brehant O,Fuks D,Bartili E, et al.Elective (planned) colectomy in patients with colorectal obstruction after placement of a self-expanding metallic stent as a bridge to surgery: the results of a prospective study.Colorectal Dis. 2009;11 (2): 178-183.
23. Nagula S,Ishill N,Nash C, et al.Quality of life and symptom control after stent placement or surgical palliation of malignant colorectal obstruction.J Am Coll Surg. 2010;210 (1): 45-53.
24. Trompetas V.Emergency management of malignant acute left-sided colonic obstruction.Ann R Coll Surg Engl. 2008;90 (3): 181-186.
25. Finan PJ,Campbell S,Verma R, et al.The management of malignant large bowel obstruction: ACPGBI position statement.Colorectal Dis. 2007;9 (suppl): 1S-17S.
26. Cheung HYS,Chung CC,Tsang WWC, et al.Endolaparoscopic approach vs conventional open surgery in the treatment of obstructing left-sided colon cancer: a randomized controlled trial.Arch Surg. 2009;144 (12): 1127-1132.
27. Kuhry E,Schwenk W,Gaupset R,Romild U,Bonjer HJ.Long-term results laparoscopic colorectal cancer resection.Cochrane Database Syst Rev. 2008;4:.
28. Feuer DDJ,Broadley KE.Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.Cochrane Database Syst Rev. 2009;1:.
29. Roeland E,von Gunten CF.Current concepts in malignant bowel obstruction management.Curr Oncol Rep. 2009;11 (4): 298-303.
30. Brooksbank MA,Game PA,Ashby MA.Palliative venting gastrostomy in malignant intestinal obstruction.Palliat Med. 2002;16 (6): 520-526.
31. Baron TH.Interventional palliative strategies for malignant bowel obstruction.Curr Oncol Rep. 2009;11 (4): 293-297.
32. Sparrow P,David E,Pugash R.Direct percutaneous jejunostomy-an underutilized interventional technique.Cardiovasc Intervent Radiol. 2008;31 (2): 336-341.
33. Mackey R,Chand B,Oishi H,Kameoka S,Panksy JL.Percutaneous transesophageal gastrostomy tube for decompression of malignant obstruction: report of the first case and our series in the US.J Am Coll Surg. 2005;201 (5): 695-700.
34. Udomsawaengsup S,Brethauer S,Kroh M,Chand B.Percutaneous transesophageal gastrostomy (PTEG): a safe and effective technique for gastrointestinal decompression in malignant obstruction and massive ascites.Surg Endoscopy. 2008;22 (10): 2314-2318.
35. Singal AK,Dekovich AA,Tam AL,Wallace MJ.Percutaneous transesophageal gastrostomy tube placement: an alternative to percutaneous endoscopic gastrostomy in patients with intra-abdominal metastasis.Gastrointest Endosc. 2010;71 (2): 402-406.
36. Feuer DJ,Broadley KE.Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.Cochrane Database Syst Rev. 2009;1:.
37. Mercadante S,Ferrera P,Villari P,Marrazzo A.Aggressive pharmacologic treatment for reversing malignant bowel obstruction.J Pain Symptom Manage. 2004;28 (4): 412-416.
38. Dunn GD.Palliating patients who have unresectable colon cancer: creating the right framework and salient symptom management.Surg Clin N Am. 2006;86 (4): 1065-1092.
39. Ripamonti C,Mercadante S,Grof L, et al.Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial.J Pain Symptom Manage. 2000;19 (1): 23-34.
40. Davis MP,Furste A.Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction.J Pain Symptom Manage. 1999;18 (3): 153-154.
41. Glare P,Pereira G,Kristjanson LJ,Stockler M,Tattersall M.Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.Support Care Cancer. 2004;12 (6): 432-440.
42. Anthony T,Baron T,Mercadante S, et al.Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction.J Pain Symptom Manage. 2007;34 (suppl): 49S-59S.
43. Ripamonti C,Bruera E.Palliative management of malignant bowel obstruction.Int J Gynecol Cancer. 2002;12 (2): 135-143.
44. Mercadante S,Casuccio A,Mangione S.Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review.J Pain Symptom Manage. 2007;33 (2): 217-223.
45. Matulonis UA,Seiden MV,Roche M, et al.Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.J Pain Symptom Manage. 2005;30 (6): 563-569.
46. Morita T,Tei Y,Inoue S,Suga A,Chihara S.Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study.Support Care Cancer. 2002;10 (6): 474-479.
47. Bruera E,Sala R,Rico MA, et al.Effects of parenteral hydration in terminally ill cancer patients: a preliminary study.J Clin Oncol. 2005;23 (10): 2366-2371.
48. DiBaise JK,Scolapio JS.Home parenteral and enteral nutrition.Gastroenterol Clin N Am. 2007;36:123-144.
49. Pasanisi F,Orban A,Scalfi L, et al.Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition.Nutrition. 2001;17 (7-8): 5581-5584.
50. Hoda D,Jato A,Burnes J,Loprinzi C,Kelly D.Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience.Cancer. 2005;103 (4): 863-868.
51. Abu-Rustum NR,Barakat RR,Venkatraman E,Spriggs D.Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction.Gynecol Oncol. 1997;64 (3): 493-495.
52. Brard L,Weitzen S,Strubel-Lagan SL, et al.The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.Gynecol Oncol. 2006;103 (1): 176-180.
53. Soo I,Gramlich L.Use of parenteral nutrition in patients with advanced cancer.Appl Physiol Nutr Metab. 2008;33 (1): 102-106.
54. Pameijer CR,Mahvi DM,Stewart JA,Weber SM.Bowel obstruction in patients with metastatic cancer.Int J Gastroint Cancer. 2005;35 (2): 127-133.
55. Wright FC,Chakraborty A,Helyer L,Moravan V,Selby D.Predictors of survival in patients with non-curative stage IV cancer and malignant bowel obstruction.J Surg Oncol. 2010;101 (5): 425-429.